Kutner Nancy G, Zhang Rebecca, Huang Yijian, Painter Patricia
USRDS Rehabilitation/Quality of Life Special Studies Center, Emory University, Atlanta, GA; Department of Rehabilitation Medicine, Emory University, Atlanta, GA.
USRDS Rehabilitation/Quality of Life Special Studies Center, Emory University, Atlanta, GA; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA.
Am J Kidney Dis. 2015 Aug;66(2):297-304. doi: 10.1053/j.ajkd.2015.01.024. Epub 2015 Mar 29.
Slow walk (gait) speed predicts functional decline, institutionalization, and mortality risks in the geriatric population. A gait speed evidence base for dialysis patient outcomes is needed.
Prospective cohort study.
SETTING & PARTICIPANTS: 752 prevalent hemodialysis (HD) patients aged 20 to 92 years evaluated in 2009 to 2012 in 7 Atlanta and 7 San Francisco clinics in a US Renal Data System special study.
Usual walk speed in meters per second, categorized as ≥0.6 m/s (baseline n=575), <0.6 m/s (baseline n=94), and unable to perform walk test (baseline n=83).
Survival; hospitalization; activities of daily living (ADL) difficulty; 36-Item Short Form Health Survey (SF-36) Physical Function score.
Cox proportional hazards models investigated gait speed and mortality over a median follow-up of 703 days. Multivariable logistic or linear regression models estimated associations of baseline gait speed with hospitalization, need for ADL assistance, and SF-36 Physical Function score after 12 months.
Participants who walked ≥0.6 m/s had 53 (9%) deaths, those who walked <0.6 m/s had 19 (20%) deaths, and those unable to walk had 37 (44%) deaths. Adjusted mortality hazard ratios were 2.17 (95% CI, 1.19-3.98) for participants who walked <0.6 m/s and 6.93 (95% CI, 4.01-11.96) for those unable to walk, compared with participants walking ≥0.6 m/s. After 12 months, compared with baseline walk speed ≥ 1.0 m/s (n=169 participants), baseline walk speed of 0.6 to <0.8 m/s (n=116) was associated with increased odds of hospitalization (OR, 2.04; 95% CI, 1.19-3.49) and ADL difficulty (OR, 3.88; 95% CI, 1.46-10.33) and a -8.20 (95% CI, -13.57 to -2.82) estimated change in SF-36 Physical Function score.
Cohort not highly representative of overall US in-center HD population.
Because walking challenges the heart, lungs, and circulatory, nervous, and musculoskeletal systems, gait speed provides an informative marker of health status. The association of gait speed with HD patients' risk for functional decline warrants continued study.
步速可预测老年人群的功能衰退、机构化照护需求及死亡风险。透析患者预后的步速证据基础亟待建立。
前瞻性队列研究。
2009年至2012年期间,在美国肾脏数据系统的一项专项研究中,对752名年龄在20至92岁的维持性血液透析(HD)患者进行了评估,这些患者来自亚特兰大的7家诊所和旧金山的7家诊所。
以米每秒为单位的日常步速,分为≥0.6米/秒(基线时n = 575)、<0.6米/秒(基线时n = 94)以及无法进行步行测试(基线时n = 83)。
生存率;住院情况;日常生活活动(ADL)困难程度;36项简短健康调查(SF - 36)身体功能评分。
Cox比例风险模型研究了中位随访703天期间的步速与死亡率。多变量逻辑回归或线性回归模型估计了基线步速与12个月后住院情况、ADL协助需求以及SF - 36身体功能评分之间的关联。
步速≥0.6米/秒的参与者中有53人(9%)死亡,步速<0.6米/秒的参与者中有19人(20%)死亡,无法行走的参与者中有37人(44%)死亡。与步速≥0.6米/秒的参与者相比,步速<0.6米/秒的参与者调整后的死亡风险比为2.17(95%置信区间,1.19 - 3.98),无法行走的参与者为6.93(95%置信区间,4.01 - 11.96)。12个月后,与基线步速≥1.0米/秒(n = 169名参与者)相比,基线步速为0.6至<0.8米/秒(n = 116)与住院几率增加(比值比,2.04;95%置信区间,1.19 - 3.49)和ADL困难程度增加(比值比,3.88;95%置信区间,1.46 - 10.33)以及SF - 36身体功能评分估计下降8.20(95%置信区间, - 13.57至 - 2.82)相关。
该队列对美国总体中心血液透析人群的代表性不强。
由于行走对心脏、肺、循环、神经和肌肉骨骼系统构成挑战,步速可作为健康状况的一项有用指标。步速与血液透析患者功能衰退风险之间的关联值得持续研究。